24 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.

University of Sharjah
Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors.

University of Sharjah
Design, synthesis, and qualitative structure-activity evaluations of novelß-secretase inhibitors as potential Alzheimer's drug leads.

University of Sharjah
Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.

University of Sharjah
Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agents.

University of Sharjah
Design and synthesis of new adamantyl derivatives as promising antiproliferative agents.

University of Sharjah
Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19.

University of Sharjah
Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigations.

University of Sharjah
Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors.

University of Sharjah
Design and synthesis of new quinoline derivatives as selective C-RAF kinase inhibitors with potent anticancer activity.

University of Sharjah
Efficient selective targeting of

University of Sharjah
Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.

University of Sharjah
Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents.

University of Sharjah
Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.

University of Sharjah
A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.

University of Sharjah
Discovery of highly potent V600E-B-RAF kinase inhibitors: Molecular modeling study.

University of Sharjah
Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.

University of Sharjah
Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors.

University of Sharjah
Synthesis, biological evaluation, and molecular docking study of sulfonate derivatives as nucleotide pyrophosphatase/phosphodiesterase (NPP) inhibitors.

University of Sharjah
Discovery of a potent p38α/MAPK14 kinase inhibitor: Synthesis, in vitro/in vivo biological evaluation, and docking studies.

University of Sharjah
Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.

University of Sharjah
Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides.

University of Sharjah
Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors.

University of Sharjah
Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.

University of Sharjah